ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Machine preservation"

  • 2018 American Transplant Congress

    Factors Predicting Viability Achievement on Discarded Donor Livers Submitted to Extra-Corporeal Machine Perfusion

    Y. Boteon,1,2 R. Laing,1,2 A. Schlegel,2 J. Attard,1,2 L. Wallace,1 A. Smith,2 T. Perera,2 J. Isaac,2 D. Mirza,2 S. Afford,1 H. Mergental.2

    1National Institute for Health Research, Birmingham Liver Biomedical Research Centre, University of Birmingham, Institute of Immunology and Immunotherapy, Birmingham, United Kingdom; 2Liver Unit, Queen Elizabeth Hospital, University Hospitals Birmingham, Birmingham, United Kingdom.

    Background: Ex-vivo machine perfusion of livers (MP) may offer superior preservation for marginal donor organs. During normothermic machine perfusion (NMP) is possible to assess liver…
  • 2018 American Transplant Congress

    Viability Outcomes for Donor Livers Discarded Due to Steatosis Following Extra-Corporeal Machine Perfusion of the Liver

    Y. Boteon,1,2 R. Laing,1,2 D. Neil,2 A. Schlegel,2 J. Attard,1,2 G. Reynold,1 P. Muiesan,2 D. Mirza,2 S. Afford,1 H. Mergental.2

    1National Institute for Health Research, Birmingham Liver Biomedical Research Centre, University of Birmingham, Institute of Immunology and Immunotherapy, Birmingham, United Kingdom; 2Liver Unit, Queen Elizabeth Hospital, University Hospitals Birmingham, Birmingham, United Kingdom.

    Background: Steatosis is the main reason for discarding donor livers worldwide. Ex-vivo machine perfusion offers superior preservation for marginal organs and permits viability testing during…
  • 2018 American Transplant Congress

    Molecular Injury and Repair Assessment in Ex Vivo Perfused Swine Heart Transplants

    N. Herbers, S. Hatami, P. Dromparis, J. Nagendran, M. Mengel, D. Freed, B. Adam.

    University of Alberta, Edmonton, Canada.

    Background: Cardiac transplantation is a life-saving intervention for advanced heart failure but it is unfortunately limited by a critical shortage of suitable donor organs and…
  • 2018 American Transplant Congress

    Use of Perfusion Machine after Long Cold Ischemia Time: 3 Years Results

    A. Matos,1 L. Requião-Moura,1 E. Tonato,1 M. Souza-Durão,1,2 M. Borrelli,1 M. Nogueira,1 P. Rubio,1 A. Pacheco-Silva.1,2

    1Transplant, Hospital Israelita Albert Einstein, São Paulo, Brazil; 2Nephrology, Universidade Federal de São Paulo, São Paulo, Brazil.

    The rate of delayed graft function (DGF) in Brazil is very high, reaching 80%. This is due to the long cold ischemia time (TIF) and…
  • 2018 American Transplant Congress

    Normothermic Machine Perfusion (NMP) Preservation for Human Liver Transplantation in the Cleveland Clinic

    Q. Liu, D. Pezzati, A. Hassan, B. Soliman, P. Grady, S. Maikhor, G. Iuppa, T. Diago Uso, K. Hashimoto, F. Aucejo, M. Fujiki, B. Eghtesad, J. Cywinski, S. Irefin, J. Fung, K. Abu-Elmagd, C. Miller, C. Quintini.

    Cleveland Clinic, Cleveland, OH.

    NMP is a novel preservation method for liver grafts. We transplanted 15 human livers after NMP to test the safety and feasibility of NMP on…
  • 2018 American Transplant Congress

    Variation in Hypothermic Machine Perfusion Utilization and Clinical Outcomes for Deceased-Donor Kidneys

    V. Krishnamoorthy,1 S. Wunsch,2 K. O'Connor,2 M. Souter.3

    1Anesthesiology, Duke University, Durham, NC; 2LifeCenter Northwest, Bellevue, WA; 3Anesthesiology and Pain Medicine, University of Washington, Seattle, WA.

    Introduction:Hypothermic machine perfusion (HMP) has been shown to be an effective method for preserving kidney allografts from deceased donors (1), but data suggests that low-risk…
  • 2018 American Transplant Congress

    Pharmacological Defatting of Steatotic Human Livers Using a Novel Perfusion Solution during Normothermic Machine Perfusion

    Y. Boteon,1,2 J. Attard,1,2 R. Laing,1,2 A. Boteon,1 R. Bhogal,1 G. Reynold,2 D. Neil,1 H. Mergental,1 D. Mirza,1 S. Afford.2

    1National Institute for Health Research, Birmingham Liver Biomedical Research Centre, University of Birmingham, Institute of Immunology and Immunotherapy, Birmingham, United Kingdom; 2Liver Unit, Queen Elizabeth Hospital, University Hospitals Birmingham, Birmingham, United Kingdom.

    Introduction: Steatosis is the leading reason for donor livers discarding and contributes significantly to the worsening shortage of organs for transplantation. Steatotic livers commonly fail…
  • 2018 American Transplant Congress

    Hypothermic Machine Perfusion Protects DCD Liver Graft through Metabolism of Xenobiotics by Cytochrome P450 Pathway

    Q. Ye,1,2 W. Liang,1 Z. Zhong,1 S. Ye,1 B. Tang,1 Q. Hu,1 J. Liang,1 Y. Wang.1

    1Transplant Center of Wuhan University, Zhongnan Hospital of Wuhan University, Wuhan, China; 2The 3rd Xiangya Hospital of Central South Unversity, Changsha, China.

    Background: Donation after cardiac death (DCD) is the mainly resource to relieve organ-transplantation shortage. Our previous research have confirmed that the function of DCD liver…
  • 2018 American Transplant Congress

    Impact of ELAD C3A Cell Conditioned Medium Enhanced Perfusate Fluid on Functional Recovery of Extended Criteria Donor Livers during Normothermic Machine Perfusion

    S. Afford,2 L. Wallace,2 R. Laing,2 Y. Botteon,2 D. He,3 S. Soundararajan,4 D. Mirza,1 R. Ashley,3 J. Brotherton,3 H. Mergental,1 D. Reich.4

    1Queen Elizabeth Hospital, Birmingham, United Kingdom; 2University of Birmingham, Birmingham, United Kingdom; 3Vital Therapies Inc, San Diego, CA; 4Drexel University, Philadelphia.

    Reconditioning of donor livers by Normothermic Machine Perfusion (NMP) is already increasing the numbers of transplantable organs from the extended criteria donors. The hepatoblastoma-derived cell…
  • 2018 American Transplant Congress

    Hypothermic Machine Perfusion Protects Rabbit Kidney Graft through Down Regulation SPP1-MMP7 Signaling Axis

    Q. Hu,1 Z. Zhong,1 S. Xue,1 W. Liang,1 J. Lan,1 J. Liang,1 Y. Xiong,1 Y. Wang,1 Q. Ye.1,2

    1Zhongnan Hospital of Wuhan University, Transplant Center of Wuhan University, Hubei Key Laboratory of Medical Technology on Transplantation, Wuhan, China; 2The 3rd Xiangya Hospital of Central Sourth University, Changsha, China.

    Background: Multicenter studies have indicated that hypothermic machine perfusion(HMP) can be used to prolong cold ischemia time with high-quality preservation and allow utilization of kidney…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 19
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences